Monthly Archives: September 2015

Xarelto Lawsuit Update: Dates for Bellwether Trials Set

September 22, 2015 – – BloodThinnerHelp.com reports today that dates have been set for the bellwether trials in the multidistrict litigation against the manufacturers of an anticoagulant called Xarelto. The lawsuits allege that Xarelto causes severe internal bleeding, serious injuries, and death. For more information on the Xarelto lawsuits, click here.

The order was issued on Friday by U.S. District Judge Eldon Fallon, the judge who is presiding over the Xarelto multidistrict litigation, or MDL. A total of four trials have been scheduled so far. Judge Fallon ordered that the first Xarelto trial will be held in the Eastern District of Louisiana on February 6, 2017 and the second one in the same district on March 13, 2017. The third trial will be held in Mississippi on April 24, 2017 and the fourth in Texas on May 30, 2017.

The Xarelto MDL:

The Xarelto MDL was formed in December 2014 after a motion to consolidate the growing number of lawsuits against the manufacturers of the anticoagulant. Since the MDL was formed, the number of lawsuits filed in it have skyrocketed and it has become one of the fastest-growing mass torts concerning a product liability claim. The MDL was formed to consolidate the lawsuits, conserve judicial resources, and speed up the pretrial litigation and discovery process for both the plaintiffs and the defendants. In addition to the federal MDL in Louisiana, a mass tort group has been established in Philadelphia to consolidate cases filed that make similar allegations against the drug’s manufacturers, Bayer AG and Janssen Pharmaceuticals, the pharmaceutical division of Johnson&Johnson

The Dangerous Side Effects of Xarelto:

Xarelto is the subject of controversy and legal action because of the dangerous side effects the drug has been linked to. Since Xarelto was released onto the United States market after receiving FDA approval in 2011, several studies have linked Xarelto to adverse events such as uncontrollable internal bleeding, brain hemorrhages, stroke, and pulmonary embolism, which almost always result in serious injury and even death in some cases. Xarelto is a much more dangerous drug than traditional blood thinners such as Warfarin because Xarelto does not come with a corresponding antidote. If a patient taking Warfarin experiences an internal bleeding event, a doctor will be able to administer vitamin K and the blood will clot again. If a patient taking Xarelto experiences an internal bleed, there is no drug that can be administered to stop the bleeding, resulting in an uncontrollable internal bleeding event. In these cases, serious life-saving medical measures must usually be taken to stop the bleeding. Many of the lawsuits allege that Xarelto’s manufacturers had prior knowledge of these serious risks associated with the drug and put the drug to market anyway.

“Now that the trial dates are set, we expect to see even more lawsuits come forward,” Xarelto attorney Marc Goldich said, “If Xarelto’s manufacturers did indeed have knowledge of the dangers of the drug, they deserve to be brought to justice. We strongly encourage anyone who feels that they have been harmed by Xarelto to contact us immediately.”

For any questions regarding this press release or the pending Xarelto litigation, please contact Marc Goldich at (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.

ReleaseID: 60004315

In New Power Morcellator Lawsuit Georgia Woman Alleges Her Cancer Was Spread By Tool

September 22, 2015 – – Tracey & Fox reported that another power morcellator lawsuit has been filed, this time in the state of Georgia.

Power morcellators are surgical tools that have been used by the medical community for decades in laparoscopic surgeries. The device consists of a hollow cylinder which is inserted into the body cavity through tiny incisions made by the surgeon. Once inside, cutting jaws are used to shred the tissue being removed and then graspers are used to pull out the small pieces through the cylinder.

In recent years, the U.S. Food and Drug Administration has investigated the possibility that power morcellators used in gynecological surgeries may disseminate undetected uterine cancer, causing metastasis of the cancer to other areas of the body. On November 24th, 2014, the FDA updated a safety warning that it had previously published in April 2014, urging doctors to stop using the morcellator for hysterectomies and myomectomies because it was estimated that “approximately 1 in 350 women undergoing hysterectomy or myomectomy for the treatment of fibroids have an unsuspected uterine sarcoma.”

This latest lawsuit, filed on July 10th, 2015, in the State Court of Gwinnett County State of Georgia under civil action number 15-C-03689-1, alleges that the LiNA Xcise Laparoscopic Morcellator which was used during the plaintiff’s supracervical hysterectomy and salpingectomy, spread her undiagnosed leiomyosarcoma.

The case states that “In cutting, shredding, and fragmenting the uterus and fibroids while still within the plaintiff, the LPM disseminated and seeded cancer throughout her abdominal cavity thereby causing and accelerating the metastases and spread of her cancer, worsening her long-term prognosis and the natural course of her cancer.” Since her diagnosis, the plaintiff has undergone aggressive chemotherapy in an attempt to slow the progression of her disease and will have to have continuous imaging studies in order to monitor and address her leiomyosarcoma.

The complaint further alleges that the “Defendants knew or should have known that when malignant tissue undergoes laparoscopic power morcellation, the resultant tissue specimens can delay diagnosis because their condition can prevent the pathologist from properly identifying and staging cancer.”

This case is just one of many that have been filed against several power morcellator manufacturers. Recently, several plaintiffs filed a motion to consolidate all power morcellator lawsuits under a Multidistrict Litigation, requesting all cases would be transferred to the U.S. District Court for the District of Kansas and assigned to the Hon. Kathryn H. Vratil.

###

Contact Tracey & Fox:

Sean Tracey
713-495-2333
440 Louisiana Street , Suite 1901
Houston, TX 77002

ReleaseID: 60004310

Missame Makeup Brushes Featured On Beauty Blogs

September 22, 2015 – – Missame LLC, a Sacramento, California based company, has announced that their professional makeup brush set has been featured on various beauty blogs. Amy Ng, spokesperson for Missame, stated, “We couldn’t be happier to be featured on these blogs. In addition to being recommended by a famed Hollywood makeup artist, we’re being talked about on so many beauty and fashion blogs.”

Moyra Mulholland, a professional makeup artist based in New York, was one of those who featured the brushes. Mulholland wrote a personal email to Missame to congratulate them on producing a vegan friendly makeup brush set.

The Stepford Guide also featured the brush set, offering information and tips on how to clean makeup brushes. The most detailed review came from Cosmetopia Digest. Blogger Renu, a self-proclaimed tomboy turned makeup addict, has an internationally recognized blog and provides insights into why these brushes are beneficial to use, including the fact that they are cruelty free and provide soft bristles for applying makeup.

Femdirection, an up and coming fashion blogger, also featured the brushes on her blog, stating that she received the makeup brush set as a surprise gift. She observed, “Now I finally have a brush for all my makeup needs; concealer, brow bone, blending, powder, etc.” The blogger went on to say that she no longer needs to use her hands to apply makeup or to get makeup on all of the objects that she comes into contact with, due to the brush set by Missame.

“Being recommended by professional makeup artist is wonderful,” responded Amy Ng. “We are proud to be able to offer these cruelty free products, and even more thrilled that the beauty and fashion world is recognizing us for them.”

Missame LLC offers a number of products, which are all designed to be natural and cruelty free, meaning they do not contain real animal hair. The brush set that is being highlighted on a number of blogs and websites offers additional benefits such as being easy to clean.

More about Missame LLC, and the products that they currently have available, can be seen on the company’s official website.

###

Contact Missamé LLC:

Amy Ng
4153000269
amyng@missame.com
2701 Del Paso Rd, Ste 130-204
Sacramento CA 95835

ReleaseID: 60004183

Magic Mist Electronic Cigarettes Claims To Lead The Pack When It Comes To Variety

There are many different kinds of E-cigs; A person may get a totally different experience in terms of taste/flavor/vapor from one E-cig to another.

Chicago, Illinois – September 22, 2015 – E-Cigs, aka Electronic Cigarettes, are a relatively new phenomenon. It used to be a horrendous experience to try to quit smoking for most people, and only few could succeed. All that changed with the invention of electronic cigarettes. People can now experience smoking without smoking. It is called “Vaping”, where a vapor is inhaled without all the harmful chemicals found in real cigarettes. In fact, there are over 1000 chemicals in a regular cigarette. Over 300 chemicals are known to be very harmful, several are poisonous. E-cig cartridges and e-liquids are available in different Nicotine strengths, which is the key to quit smoking the easy way.

Along came Magic Mist and they have shaken-up the E-cig industry. They have become the dominant force and have made their competition very anxious. Magic Mist really makes it obvious that all E-cigs are not the same. When people start vaping they normally buy an E-Cig kit which could vary from $10 to $50 or even more. However, they may not like the flavor or taste of that E-cig and might conclude that E-cigs are not for them. People often mistakenly think that all E-cigs are the same. And to even try a different E-cig, they think that they will have to buy a whole new E-cig kit again. Magic Mist solved this problem very conveniently and cheaply for people. Since Magic Mist carries compatible products for over 70 E-cig brands, people who had not enjoyed other brands of electronic cigs have had great success with this line. Without investing in a totally new kit, people can buy just 1 pack of Magic Mist Compatible cartridges for their E-cigs and get a totally different experience in terms of taste/flavor/vapor. The introduction of different flavors has made a big difference in the success of “vaping” products. Further, availability of different nicotine strengths has helped even heavy cigarette smokers to dramatically cut down their consumption by tapering off the nicotine strength until they are not using any at all.

Most cigarette smokers realize that they have a habit that could be fatal, but they feel powerless to make an attempt to quit. They should be encouraged to try E-cigs, it is a life changing experience. As these nicotine addicts reduce their nicotine intake, their body begins to rebuild itself. Nicotine cartridges are available from 24mg to 0mg. The lungs are capable of cellular regeneration, and this means fresh oxygenated air will be able to benefit their body. Their red blood cells multiply as they carry freshly oxygenated blood to all parts of the body, this is the tissue cleansing effect that makes all the difference in the world.

For complete information, please visit: www.themagicmist.com

Logo: http://www.getnews.info/wp-content/uploads/2015/09/1442905170.jpeg

Distributed by PRD Press Release Distribution

Media Contact
Company Name: Magic Mist
Contact Person: Media Relations
Email: customer.service@themagicmist.com
Phone: 844-624-4264
Address:103 Schelter Rd, Suite 20
City: Lincolnshire
State: IL
Country: United States
Website: www.themagicmist.com

ReleaseID: 514039


Source: GetNews

Protected Profits App Review Access Launched for Trading Community

September 22, 2015 – – Education trading platform, Protected Profits System, will be celebrating the launch of its binary options software by giving out a trial of the software to the trading community. It’s reported the event will take place September – October 2015.

Matt Kemble, Founder of Protected Profits, says: “We wanted to surprise everyone with our binary options software launch because we wanted to give everyone a fair opportunity to try out the software themselves so they will realize how it can help them improve their financial status. We want our customers get all the advantages they could possibly have and enjoy while trading.”

Protected Profits has thrived on the idea of standing out and making a innovations. “It’s all part of having fun and it’s going to teach people something they can really use in their lifetime and will change their financial freedom at least.” says Matt and his team.

This launch celebration is just one of the many ways Protected Profits has said to have achieved its goal in building a good reputation in the trading industry. When asked about Protected Profits, Matt Kemble said: “We think it’s going to be a real hit because it is completely unique and we know our customer have been waiting for this for a long time.”

Protected Profits is set to launch on 17th September 2015. To find out more, it’s possible to visit official website.

For further information about Protected Profits System, those interested can visit them at http://golddiggerreviews.xyz/locked

###

Contact Protected Profits LLC:

Sean Wallace
support@protectedprofits.com

ReleaseID: 60004291

In Zofran Birth Defects Lawsuit, Mother Says Drug Caused Underdeveloped Heart

September 22, 2015 – – Women across the country continue to file Zofran birth defects lawsuits, and many other parents may be eligible to file claims of their own.

Attorneys at Monheit Law, a personal injury firm based in Pennsylvania, say that more than 40 lawsuits have been brought against GlaxoSmithKline so far. Families claim the multinational corporation marketed a dangerous drug for an unapproved use, in violation of federal law.

One of the most recent lawsuits was filed on July 16, 2015 in the US District Court for the Sourthern District of Illinois. In her complaint, obtained by Monheit Law and made public at ZofranLegal.com, a single mother says Zofran caused her son’s congenital heart defects.

Michael Monheit, lead attorney at Monheit Law and sponsor of ZofranLegal.com, notes that the growing Zofran litigation began soon after two major studies found an association between the unapproved morning sickness drug and an increased risk for heart defects.

The claim was registered under case number 3:15-cv-00769. Plaintiff is a resident of Sandoval, Illinois, a small village 3 hours west of Indianapolis.

In court documents, the mother tells a harrowing tale. She says her exposure to Zofran began early in the first trimester of a 2011 pregnancy. Medical experts at the American Heart Association report that heart development begins almost immediately after conception, and continues until the eighth week of pregnancy. As many Zofran birth defects Plaintiffs have noted, this is the period in which women are most likely to be prescribed the drug.

Her son T.H. was born in 2012, the parent says. But joy would soon turn into tragedy: T.H. was quickly diagnosed with a severe congenital condition, hypoplastic right heart syndrome (HRHS).

Extremely rare, HRHS occurs when the heart’s right side fails to develop completely. In fact, the right side remains almost completely undeveloped, with tiny malformed valves and two chambers so small that pumping blood toward the lungs is nearly impossible. In most children, the pulmonary valve, which controls blood flow from the heart to the lungs, is entirely absent.

For some babies with HRHS, open-heart surgery is an option; all require immediate emergency treatment. But in severe cases, a pediatric heart transplant becomes necessary. Plaintiff claims T.H. underwent this procedure following his birth. His severely abnormal heart was physically removed, and replaced with a donor organ, his mother claims. The complaint provides no details on the outcome of the alleged procedure.

More than 1 million prescriptions for the “off label” morning sickness treatment are written to pregnant women every year. While over 40 Zofran birth defects lawsuits have been filed so far, Michael Monheit says there may be many other women who were prescribed Zofran during the first trimester and had children with heart defects. His law firm is offering free consultations to any family looking for information on their legal options. Call 1-877-620-8411 to learn more.

###

Contact ZofranLegal.com:

Michael Monheit
1-877-620-8411
michael@monheit.com
1368 Barrowdale Road, Rydal, PA 19046

ReleaseID: 60004314

​Landmark Study Releases Early Findings Advising New Blood Pressure Standard

VascuVite has released the latest statement from the National Heart, Lung, and Blood Institute in an ongoing effort to ensure communities understand the importance of maintaining healthy blood pressure levels. Read more here

Tampa, FL, United States – September 22, 2015 /PressCable/

The National Heart, Lung, and Blood Institute, NHLBI, just released the initial findings of the Systolic Blood Pressure Intervention Trial, SPRINT — two years earlier than expected. The pioneering clinical trial, sponsored by the National Institutes of Health, reported that an increased intensive management of hypertension below the recommended protocol will significantly reduce cardiovascular disease and the risk of death for people who are 50 years and older.

Gary H. Gibbons, M.D., director of the NHLBI, explained the decision for the timing of the release, “This study provides potentially lifesaving information that will be useful to health care providers as they consider the best treatment options for some of their patients, particularly those over the age of 50. We are delighted to have achieved this important milestone in the study in advance of the expected closure date for the SPRINT trial and look forward to quickly communicating the results to help inform patient care and the future development of evidence-based clinical guidelines.”

SPRINT – the largest study of this kind in history — examined the positive effects of a new lower standard for systolic blood pressure levels in 9,300 diverse participants age 50 and older who are at an increased risk for heart disease or who have kidney disease. Their website states “High blood pressure is a leading cause of death and disability in the US and worldwide. Over 60 % of people over age 65 have high blood pressure and the number of people with high blood pressure is increasing.”

The first study on systolic pressure, previously published in 1991, concluded the systolic blood pressure standard should be less than 150 mm Hg for heart attack and stroke prevention – but historically few have considered the benefits of a lower standard.

Dr. William C. Cushman, chief of preventative medicine at V.A. Medical Center in Memphis explains the discrepancy “The general thinking – incorrectly – was that as you get older, the systolic naturally goes up. The epidemiology is consistent that having a systolic pressure of 120 or even below 120 is associated with reduced cardiovascular mortality. But that doesn’t necessarily mean that treating with medications to reach that level will give you that benefit.”

This is a valid concern many doctors agree is worth consideration because many of the drugs used to treat high blood pressure can cause a plethora of side effects, and although they may lower levels, they aren’t able to provide the same health benefits that come with lowering blood pressure naturally.

VascuVite is a health and wellness company whose focus is natural cardiovascular blood pressure support. Learn more at http://vascuvite.com/resources/new-blood-pressure-standard

For more information about us, please visit http://www.vascuvite.com

Contact Info:
Name: Fiona Jones
Organization: VascuVite
Phone: 1-800-777-4914

Release ID: 91903

A Brewing Bucha Opportunity in the Functional Beverage Space

REDONDO BEACH, CA / ACCESSWIRE / September 22, 2015 / The craft brewing industry may be
struggling amid intensifying competition, with companies like Craft Brew
Alliance Inc. (NASDAQ: BREW) falling some 36% over the past 52 weeks, but
there’s another type of brew that has been taking off over the past couple of
years.

Kombucha is a brewed and fermented probiotic
tea that could grow from $122.7 million in 2013 to upwards of $500 in 2015. In
many Whole Foods Inc. (NASDAQ: WFM) stores, for instance, the category accounts
for about
a third
of its refrigerated functional beverage shelf space. The market
also remains rather fragmented with only one market leader – GT – and a number
of much smaller competitors looking to secure a share of the market.

Despite its introduction thousands
of years ago, consumers have just now been embracing kombucha in increasing
numbers due to its perceived healing and cleansing characteristics. Kombucha
teas include probiotics from the fermentation and a number of potentially
beneficial byproducts found in the tea itself, such as polyphenols,
antioxidants, and flavonoids. Some manufacturers are also developing coffee,
beer, and other styles of kombucha.

In this article, we’ll take a look
at a company that’s leveraging its experience in craft brewing to introduce a
revolutionary kombucha product into health and grocery stores nationwide.

Capitalizing on Kombucha

American Brewing Co. Inc. (OTCBB:
ABRW) is a Washington-based craft brewer with four beers in its portfolio,
including the Flying Monkey Dogfight Pale Ale, Breakaway IPA, American Blonde,
and Caboose Oatmeal Stout. After getting its start in the beer industry, the
company expanded into the kombucha category with its bucha(TM) Live Kombucha brand
of gluten-free, organic, sparkling kombucha teas back in April of 2015 with
distribution throughout North America.

When the company was acquired there
was distribution into 1800 stores including health, natural and grocery chains.
The company is looking to double that store count over the next 12 months with
distribution into all major U.S. markets utilizing a new national broker
network.

Its proprietary blend
differentiates itself from other kombucha producers through its proprietary
extraction process that reduces the sour taste and may appeal to a larger
audience. In fact, the sour nature of most kombucha could be a leading factor
that’s holding back wider consumer adoption.

Profitable & Growing

American Brewing reported revenue
of $940,007, gross profit of $326,628, and net income of $19,217 during the
quarter ended June 30, 2015. Following the acquisition of bucha(TM) Live Kombucha,
the company generated 73% of its revenue and 84% of its gross profit from its
bucha tea Wholesale division. The oversized impact on gross profit suggests
that the transition into kombucha will continue improving overall margins over
time.

Figure 1 – Q2 Earnings – Source: SEC Filings

In terms of near-term potential, investors
may want to take a look at Reed’s Inc. (NYSE: REED) success in entering the
market. Reed’s reported second quarter kombucha sales that increased 11% as it
worked to improve its production techniques and add additional flavors –
including the addition of a coffee-based kombucha. According to their 10-K
filing, kombucha has grown to account for about 12% of the company’s $43.4
million in net sales – or about $9.5 million.

American Brewing has a market
capitalization of just $7 million, which leaves substantial room for upside if
can capture just a fraction of the market. Reed’s trades with a price-sales
ratio of about 1.4x, while many larger beverage companies trade with even
higher multiples. The company’s pure-play focus on kombucha could lead to an
above-market multiple, since it would presumably be able to grow faster than
its diversified competitors.

Looking Ahead

Kombucha is the largest growth
segment of the functional beverage category of food and drinks, which includes
coconut water, yogurts, and fresh juices. The refrigerated juices section of
the market alone grew by approximately $200 million in 2012 to an estimated
market of about $600 million (50% growth), according to SPINS data. Kombucha
accounts for an overwhelming majority of that explosive growth and accounts for
a large part of the segment.

With its growing distribution
footprint and product innovation, American Brewing is well-positioned to become
a virtual-pure-play in the kombucha space. Investors interested in the
functional beverage space may want to take a closer look at the stock given
these catalysts. In particular, investors in micro-cap functional beverage
stocks, like DC Brands International Inc. (OTC Pink: HRDN), or nutraceutical
firms, like Nutraceutical Int’l Corp. (NASDAQ: NUTR), may want to take an
especially close look at the stock.

For more information, visit the
company’s website at www.americanbrewing.com.

Legal Disclaimer:

Except for the historical information presented herein, matters
discussed in this release contain forward-looking statements that are
subject to certain risks and uncertainties that could cause actual
results to differ materially from any future results, performance or
achievements expressed or implied by such statements. Emerging Growth
LLC is not registered with any financial or securities regulatory
authority, and does not provide nor claims to provide investment advice
or recommendations to readers of this release. Emerging Growth LLC may
from time to time have a position in the securities mentioned herein and
may increase or decrease such positions without notice. For making
specific investment decisions, readers should seek their own advice.
Emerging Growth LLC may be compensated for its services in the form of
cash-based compensation or equity securities in the companies it writes
about, or a combination of the two. For full disclosure please visit: http://secfilings.com/Disclaimer.aspx.

SOURCE: Emerging Growth LLC

ReleaseID: 432120

Focusky Re-launched Business Presentation Software with New Demonstrations

At a recent press-conference held at the headquarters of the city, the spokesperson for Focusky Software Co. Ltd had reportedly confirmed the company’s recent introduction of the business presentation software.

The company made famous after its completely individualized software for presentations including business presentations much like Power-point presentations. However with the business presentation software from Focusky one has an obvious upgrade. It can readily import videos online which is an obvious set back with the Power-point as it cannot do the same. This in turn gives the Focusky software an obvious advantage over its counterparts because they limit the presentations to boring one-way presentations. The software from the house of Focusky also allows the users to draw shapes in the software to give more clarity to the individual mind-mapping setting ideas.

Thus users have obvious advantages with the Focusky product. Jason Chen the President of Focusky has stressed on the fact that the new product allows a beautiful sequence for story-telling. The software comes with two amazing features namely the Zooming Canvas feature and the Inspire presentation which in turn allows users to engage the audience to the presentation providing it with an additional edge. Even without the help of portable USBs it accounts for uploading the video on an online platform directly through the server.

The software comes with a 30-days money refund policy and has relaxed purchase laws. The paid and the unpaid version both are somewhat similar but the paid version comes with no watermark of Focusky over the slides while the unpaid counterpart of the presentation software comes with a watermark of the company logo and name over the slides. The company is engaged in giving more facilities available to the paid customers.

Another benefit for the business presentation software is that once purchased, users can use it for a lifetime while it updates on its own for free. English is the language supported by the interface but the software allows languages all around the globe to be put into the presentation such as Chinese, Korean, Latin, Japanese and German and so on.

People interested in this news post may also want to learn more: Brand Enterprise with Business Presentation Software.

To watch the engaging presentation example, visit: http://focusky.com/

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/09/1411008451.jpeg

“Focusky Business Presentation Software”

Media Contact
Company Name: Focusky
Contact Person: Lailie Tan
Email: pr@focusky.com
Phone: +86 13119535729
Address:G/F, Far East Consortium Building, 23 Des Voeux Road, Central
City: Hong Kong
Country: China
Website: http://focusky.com/

Source: ABNewswire

ReleaseID: 38212

Creator of NoRadi Phone Insert Launches IndieGoGo Campaign

The creator of NoRadi, a phone case insert that protects against harmful electromagnetic radiation, has launched an IndieGoGo campaign to raise production and marketing funds.

NoRadi is an insert that fits into the case of any cell phone and absorbs electromagnetic radiation that could be harmful to the user. Now, the creator of this ingenious device has launched an IndieGoGo campaign to raise funds for production and marketing of NoRadi to a larger audience.

According to reports, the World Health Organization and International Agency for Research on Cancer have classified the radiation emitted by cell phones as a potential carcinogen, placing it is the 2B group of “suspected carcinogen for humans.” Because of the close proximity to the body when using or carrying a cell phone, users are at particular risk from this type of radiation. Studies have suggested that users may develop certain cancers due to this exposure.

NoRadi solves this problem by shielding the user from harmful electromagnetic radiation. The insert fits into any cell phone case; there is also a version for tablets and PCs. NoRadi uses a Z-type hexaferrite with a powder silicone binding agent. This patented technology makes the radiation from a phone harmless by absorbing up to 60 percent of emitted rays. “While other products may claim to block 99 percent of the electromagnetic energy from a cell phone, this is impossible,” notes the creator. “Instead, NoRadi reasonably claims that the product stops up to 60 percent of electromagnetic radiation, which gives the user a great degree of protection and still allows the phone to work.”

As seen at https://www.indiegogo.com/projects/noradi-stop-phone-radiation#/story, the IndieGoGo campaign offers pledge levels from $24 to $199 and perks from NoRadi inserts to phone, tablet and PC cases.

For more information on the prizes associated with each pledge level, see the IndieGoGo page.

About NoRadi:

NoRadi is an insert that protects cell phone users from harmful electromagnetic energy and radiation that can emit from their devices. The creator of NoRadi is raising funds for production and distribution through an IndieGoGo campaign.

Media Contact
Company Name: NoRadi
Contact Person: Richard Mamut
Email: noradi.info@gmail.com
Phone: 380992315643
City: Sheffield
Country: United Kingdom
Website: https://www.indiegogo.com/projects/noradi-stop-phone-radiation#/story

Source: ABNewswire

ReleaseID: 38216